National Institute on Drug Abuse; Amended Notice of Meeting

---
identifier: "/us/fr/2020-05632"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Institute on Drug Abuse; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2020-05632"
section_name: "National Institute on Drug Abuse; Amended Notice of Meeting"
positive_law: false
currency: "2020-03-18"
last_updated: "2020-03-18"
format_version: "1.1.0"
generator: "[email protected]"
agency: "DEPARTMENT OF HEALTH AND HUMAN SERVICES"
document_number: "2020-05632"
document_type: "notice"
publication_date: "2020-03-18"
agencies:
  - "DEPARTMENT OF HEALTH AND HUMAN SERVICES"
  - "National Institutes of Health"
---


#  National Institute on Drug Abuse; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Institute on Drug Abuse Special Emphasis Panel, March 26, 2020, 8:00 a.m. to 5:00 p.m., Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852, which was published in the *Federal Register* on February 28, 2020, 85 FR 11998.

This meeting is amended to change the meeting location and format. The meeting will now be held as a teleconference at the National Institutes of Health, Neurosciences Center Building, 6001 Executive Boulevard, Room 4236, Rockville, MD 20852. The meeting is closed to the public.

Dated: March 12, 2020.

Tyeshia M. Roberson,

Program Analyst, Office of Federal Advisory Committee Policy.